Cancer52 has prepared a briefing for a Westminster Hall Debate  on the ‘Potential merits of a cancer strategy for England’ . The debate...

Patient Organisation Statement on NHS England Commercial Framework Consultation

Interim CEO, Sasha Daly was pleased to meet with Minister Andrew Gwynne to talk through cancer services and how Cancer52 can work in partner

Cancer52 is delighted to announce the appointment of Chris Walden as our new CEO.

Longstanding CEO, Jane Lyons stepped down on Monday 15th July. Sasha Daly , Director for Policy at Cancer52, is Interim CEO during the...

Cancer52 has launched a manifesto called   ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...

Cancer52 recently hosted The Big Cancer52 Conversation at Level39 in Canary Wharf. This was the third Big Cancer52 Conversation, and...

Cancer52 is pleased to launch  ‘The Other Half. A manifesto to transform outcomes for people with rare and less common cancers’. The...

Cancer52 are delighted to welcome The Young Tongues as the latest member to join Cancer52. The Young Tongues provide peer-to-peer support...

Cancer52 is proud to share its Annual Review for the financial year 2022-2023. As ever it is a great opportunity to look back at what has...